{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:58:58Z","timestamp":1767974338680,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s12664-022-01258-z","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T05:02:35Z","timestamp":1661230955000},"page":"343-351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Monotherapy with thiopurines in stricturing Crohn\u2019s disease: A real-life experience from low- and middle-income countries"],"prefix":"10.1007","volume":"41","author":[{"given":"Bhaskar","family":"Kante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudheer Kumar","family":"Vuyyuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Kedia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pabitra","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peeyush","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh Kumar","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubi","family":"Virmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raju","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumble Seetharama","family":"Madhusudhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Panwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasenjit","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Govind","family":"Makharia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5474-9709","authenticated-orcid":false,"given":"Vineet","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"key":"1258_CR1","doi-asserted-by":"crossref","unstructured":"Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn's disease. Lancet. 2017;389:1741\u201355.","DOI":"10.1016\/S0140-6736(16)31711-1"},{"key":"1258_CR2","doi-asserted-by":"crossref","unstructured":"Amitai MM, Klang E, Levartovsky A, et al. Diffusion-weighted magnetic resonance enterography for prediction of response to tumor necrosis factor inhibitors in stricturing Crohn\u2019s disease.\u00a0Abdom Radiol (NY). 2018;43:3207\u201312.\u00a0","DOI":"10.1007\/s00261-018-1626-9"},{"key":"1258_CR3","doi-asserted-by":"crossref","unstructured":"Bouhnik Y, Carbonnel F, Laharie D, et al. Efficacy of adalimumab in patients with Crohn\u2019s disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study. Gut. 2018;67:53\u201360.","DOI":"10.1136\/gutjnl-2016-312581"},{"key":"1258_CR4","doi-asserted-by":"crossref","unstructured":"Gibson DJ, Murphy DJ, Smyth AE, et al. Magnetic resonance enterography findings as predictors of clinical outcome following antitumor necrosis factor treatment in small bowel Crohn\u2019s disease. Eur J Gastroenterol Hepatol. 2015;27:956\u201362.","DOI":"10.1097\/MEG.0000000000000399"},{"key":"1258_CR5","doi-asserted-by":"crossref","unstructured":"Pallotta N, Barberani F, Hassan NA, Guagnozzi D, Vincoli G, Corazziari E. Effect of infliximab on small bowel stenoses in patients with Crohn's disease. World J Gastroenterol. 2008;14:1885\u201390.\u00a0","DOI":"10.3748\/wjg.14.1885"},{"key":"1258_CR6","doi-asserted-by":"crossref","unstructured":"Condino G, Calabrese E, Zorzi F, et al. Anti-TNF-alpha treatments and obstructive symptoms in Crohn\u2019s disease: a prospective study.\u00a0Dig Liver Dis. 2013;45:258\u201362.","DOI":"10.1016\/j.dld.2012.10.009"},{"key":"1258_CR7","doi-asserted-by":"crossref","unstructured":"Campos C, Perrey A, Lambert C, et al. Medical therapies for stricturing Crohn\u2019s disease: efficacy and cross-sectional imaging predictors of therapeutic failure. Dig Dis Sci. 2017;62:1628\u201336.\u00a0","DOI":"10.1007\/s10620-017-4572-4"},{"key":"1258_CR8","doi-asserted-by":"crossref","unstructured":"Pelletier AL, Kalisazan B, Wienckiewicz J, Bouarioua N, Soul\u00e9 JC. Infliximab treatment for symptomatic Crohn's disease strictures. Aliment Pharmacol Ther. 2009;29:279\u201385.","DOI":"10.1111\/j.1365-2036.2008.03887.x"},{"key":"1258_CR9","doi-asserted-by":"crossref","unstructured":"Lu C, Baraty B, Lee Robertson H, et al. Systematic review: medical therapy for fibrostenosing Crohn\u2019s disease. Aliment Pharmacol Ther. 2020;51:1233\u201346.\u00a0","DOI":"10.1111\/apt.15750"},{"key":"1258_CR10","doi-asserted-by":"crossref","unstructured":"Bettenworth D, Gustavsson A, Atreja A, et al. A pooled analysis of efficacy, safety, and long-term outcome of endoscopic balloon dilation therapy for patients with stricturing Crohn\u2019s disease. Inflamm Bowel Dis. 2017;23:133\u201342.\u00a0","DOI":"10.1097\/MIB.0000000000000988"},{"key":"1258_CR11","doi-asserted-by":"crossref","unstructured":"Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn\u2019s disease. Inflamm Bowel Dis. 2002;8:244\u201350.\u00a0","DOI":"10.1097\/00054725-200207000-00002"},{"key":"1258_CR12","doi-asserted-by":"crossref","unstructured":"Nguyen NH, Singh S, Sandborn WJ. Positioning therapies in the management of Crohn\u2019s disease. Clin Gastroenterol Hepatol. 2020;18:1268\u201379.\u00a0","DOI":"10.1016\/j.cgh.2019.10.035"},{"key":"1258_CR13","doi-asserted-by":"crossref","unstructured":"Gomoll\u00f3n F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: Part 1: Diagnosis and medical management. J Crohns Colitis. 2017;11:3\u201325.\u00a0","DOI":"10.1093\/ecco-jcc\/jjw168"},{"key":"1258_CR14","doi-asserted-by":"crossref","unstructured":"Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study. Gastroenterology. 1976;70:439\u201344.","DOI":"10.1016\/S0016-5085(76)80163-1"},{"key":"1258_CR15","doi-asserted-by":"crossref","unstructured":"Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68:s1\u2013s106.","DOI":"10.1136\/gutjnl-2019-318484"},{"key":"1258_CR16","doi-asserted-by":"crossref","unstructured":"Feuerstein JD, Ho EY, Shmidt E, et al. AGA clinical practice guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn\u2019s disease. Gastroenterology. 2021;160:2496\u2013508.\u00a0","DOI":"10.1053\/j.gastro.2021.04.022"},{"key":"1258_CR17","doi-asserted-by":"crossref","unstructured":"Rieder F, Bettenworth D, Ma C, et al. An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn\u2019s disease. Aliment Pharmacol Ther. 2018;48:347\u201357.\u00a0","DOI":"10.1111\/apt.14853"},{"key":"1258_CR18","doi-asserted-by":"crossref","unstructured":"Verstockt B, Boets L, Sabino J, Vermeire S, Ferrante M. Thiopurine monotherapy has a limited place in treatment of patients with mild-to-moderate Crohn's disease. Gut. 2021;70:1416\u20138.\u00a0","DOI":"10.1136\/gutjnl-2020-322646"},{"key":"1258_CR19","doi-asserted-by":"crossref","unstructured":"Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007;13:1545\u201353.\u00a0","DOI":"10.1002\/ibd.20285"},{"key":"1258_CR20","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Lago I, Hoyo JD, P\u00e9rez-Girb\u00e9s A, et al. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn\u2019s disease. United Eur Gastroenterol J. 2020;8:1056\u201366.","DOI":"10.1177\/2050640620947579"},{"key":"1258_CR21","doi-asserted-by":"crossref","unstructured":"Rosenberg JL, Levin B, Wall AJ, Kirsner JB. A controlled trial of azathioprine in Crohn\u2019s disease. Am J Dig Dis. 1975;20:721\u20136.","DOI":"10.1007\/BF01070829"},{"key":"1258_CR22","doi-asserted-by":"crossref","unstructured":"Candy S, Wright J, Gerber M, Adams G, Gerig M, Goodman R. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut. 1995;37:674\u20138.","DOI":"10.1136\/gut.37.5.674"},{"key":"1258_CR23","doi-asserted-by":"crossref","unstructured":"Yu LF, Zhong J, Cheng SD, Tang YH, Miao F. Low-dose azathioprine effectively improves mucosal healing in Chinese patients with small bowel Crohn's disease. J Dig Dis. 2014;15:18\u20137.\u00a0","DOI":"10.1111\/1751-2980.12127"},{"key":"1258_CR24","doi-asserted-by":"crossref","unstructured":"Chande N, Patton PH, Tsoulis DJ, Thomas BS, MacDonald JK. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2015;CD000067.","DOI":"10.1002\/14651858.CD000067.pub3"},{"key":"1258_CR25","doi-asserted-by":"crossref","unstructured":"Pearson D, May G, Fick G, Sutherland L. Azathioprine for maintenance of remission in Crohn\u2019s disease. In: The Cochrane Collaboration, ed. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd; 1998:CD000067.","DOI":"10.1002\/14651858.CD000067"},{"key":"1258_CR26","doi-asserted-by":"crossref","unstructured":"de Souza GS, Vidigal FM, Chebli LA, et al. Effect of azathioprine or mesalazine therapy on incidence of re-hospitalization in sub-occlusive ileocecal Crohn\u2019s disease patients. Med Sci Monit. 2013;19:716\u201322.","DOI":"10.12659\/MSM.889196"},{"key":"1258_CR27","doi-asserted-by":"crossref","unstructured":"Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut. 2002;50:485\u20139.\u00a0","DOI":"10.1136\/gut.50.4.485"},{"key":"1258_CR28","doi-asserted-by":"crossref","unstructured":"Kim JH, Cheon JH, Hong SS, et al. Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study. J Clin Gastroenterol. 2010;44:e242\u20138.","DOI":"10.1097\/MCG.0b013e3181d6baf5"},{"key":"1258_CR29","doi-asserted-by":"crossref","unstructured":"Qiu Y, Mao R, Zhang S, et al. Safety profile of thiopurines in Crohn disease: analysis of 893 patient-years follow-Up in a Southern China cohort. Medicine (Baltimore). 2015;94:e1513.","DOI":"10.1097\/MD.0000000000001513"},{"key":"1258_CR30","doi-asserted-by":"crossref","unstructured":"Takatsu N, Matsui T, Murakami Y, et al. Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2009;24:1258\u201364.\u00a0","DOI":"10.1111\/j.1440-1746.2009.05917.x"},{"key":"1258_CR31","doi-asserted-by":"crossref","unstructured":"Parkar SP, Dherai AJ, Desai DC, Ashavaid TF. Thiopurine metabolite level and toxicity in Indians with inflammatory bowel disease. JGH Open. 2017;1:25\u201331.\u00a0","DOI":"10.1002\/jgh3.12004"},{"key":"1258_CR32","doi-asserted-by":"crossref","unstructured":"Wu J, Gao Y, Yang C, Yang X, Li X, Xiao S. Low-dose azathioprine is effective in maintaining remission among Chinese patients with Crohn's disease. J Transl Med. 2013;11:235.\u00a0","DOI":"10.1186\/1479-5876-11-235"},{"key":"1258_CR33","doi-asserted-by":"crossref","unstructured":"Qian X, Wang T, Shen J, Ran Z. Low dose of azathioprine is effective to induce and maintain remission in active Crohn disease: a prospective observational study. Medicine (Baltimore). 2018;97:e11814.\u00a0","DOI":"10.1097\/MD.0000000000011814"},{"key":"1258_CR34","doi-asserted-by":"crossref","unstructured":"Takatsu N, Matsui T, Murakami Y, et al. Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2009;24:1258\u201364.\u00a0","DOI":"10.1111\/j.1440-1746.2009.05917.x"},{"key":"1258_CR35","doi-asserted-by":"crossref","unstructured":"Matsuoka K. NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease. Intest Res. 2020;18:275\u201381.\u00a0","DOI":"10.5217\/ir.2020.00002"},{"key":"1258_CR36","doi-asserted-by":"crossref","unstructured":"Kotlyar DS, Lewis JD, Beaugerie L, et al. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. Clin Gastroenterol Hepatol. 2015;13:847\u201358.e4.","DOI":"10.1016\/j.cgh.2014.05.015"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-022-01258-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-022-01258-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-022-01258-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T01:13:08Z","timestamp":1664845988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-022-01258-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1258"],"URL":"https:\/\/doi.org\/10.1007\/s12664-022-01258-z","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"27 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BK, SSV, SK, PS, PK, MKR, SV, RS, KSM, RP, PD, GM, and VA declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed conforming to the Helsinki declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer\/publishers are responsible for the results\/findings and content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}